Recurrent Small Cell Lung Cancer: Clinical Trials

2 trials for Recurrent Small Cell Lung Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Withdrawn 1

Follow Recurrent Small Cell Lung Cancer: new trials by email Literature Review of Recurrent Small Cell Lung Cancer trials Research Report on Recurrent Small Cell Lung Cancer

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
exercise intervention, standard follow-up care, quality-of-life assessment - Extensive Stage Small Cell Lung Cancer, Healthy, no Evidence of Disease
Not applicableCompletedUniversity of Wisconsin, Madison212013-12-012019-11-18
Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body
cryotherapy, quality-of-life assessment - Advanced Malignant Mesothelioma, Extensive Stage Small Cell Lung Cancer
Not applicableWithdrawnWake Forest University Health Sciences2011-03-012018-07-03

Narrower conditions

Carcinoma, Non-Small-Cell Lung (2)  ·  Small Cell Lung Carcinoma (2)  ·  Mesothelioma, Malignant (1)

Broader conditions

Bronchial Neoplasms (2)  ·  Carcinoma, Bronchogenic (2)  ·  Lung Diseases (2)  ·  Lung Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Neoplasms (2)  ·  Thoracic Neoplasms (2)  ·  Adenoma (1)  ·  Mesothelioma (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Mesothelial (1)  ·  Pleural Neoplasms (1)

Interventions

Cryotherapy (1)

Sponsors

University of Wisconsin, Madison (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (1)

Top investigators

James Urbanic (1)  ·  Toby Campbell (1)

NIH funding

P30CA014520 (1)